|
Zhejiang Huahai Pharmaceutical - Company Profile Snapshot
| Company Profile: |
Zhejiang Huahai Pharmaceutical |
| Ticker: |
600521 |
| Exchanges: |
SHG |
| 2008 Sales: |
790,640,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
CHINA |
| Employees: |
2586 |
Business Description
Zhejiang Huahai Pharmaceutical. The Group's principal activities are the research, development, manufacture and sale of pharmaceutical products. Main products include intermediates, medicines in the form of capsule and tablets, captopril, ketotifen fumarate, dobutamine hydrochloride, nimodipine, enlapril maleate, lisinopril, valsartan, paroxetine hydrochloride, irbesartan, quinapril hydrochloride, losartan potassium and others. It also offers technical services.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
